ALB and hypertensive disorder: Increased urinary albumin excretion has been acknowledged as a powerful and independent predictor of prognosis in several disease states, such as diabetes, hypertension [35], and heart failure [36], and has been consistently used as a surrogate endpoint in therapeutic trials [37] for both cardiovascular and renal outcomes.